Cargando…
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects
The prognosis of patients with systemic lupus erythematosus has greatly improved since treatment regimens combining corticosteroids and immunosuppressive medications have been widely adopted in therapeutic strategies given to these patients. Immune suppression is evidently efficient but also leads t...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714128/ https://www.ncbi.nlm.nih.gov/pubmed/19591653 http://dx.doi.org/10.1186/ar2711 |